New Data Presented at the American Psychiatric Association Annual Meeting May Shape the Standard of Care for Bipolar Disorder
05 Mai 2004 - 11:00PM
PR Newswire (US)
New Data Presented at the American Psychiatric Association Annual
Meeting May Shape the Standard of Care for Bipolar Disorder NEW
YORK, May 5 /PRNewswire/ -- "These preliminary findings should
shape the standard of care for bipolar disorder going forward,"
says Joseph Calabrese, MD, co-Director of the National Institute of
Mental Health Bipolar Research Center at University Hospitals of
Cleveland and Case Western Reserve University. The condition
(bipolar I and II) affects approximately 8 million Americans, who
have relied on a combination of drugs to manage their symptoms. For
the first time, researchers have demonstrated in separate
short-term trials that a single drug therapy may be effective in
treating both the manic and depressive phases of bipolar disorder.
Dr. Calabrese will present these data at the annual meeting of the
American Psychiatric Association in New York City on Wednesday, May
5 beginning at 3pm. ADDITIONAL RESOURCES: Video version and more
available at
http://www.prnewswire.com/broadcast/12208/consumer.shtml
SOUNDBITES: Joseph Calabrese, MD, Co-Director of the National
Institute of Mental Health Bipolar Research Center at University
Hospitals of Cleveland and Case Western Reserve University. VIDEO
PROVIDED BY: AstraZeneca
http://www.prnewswire.com/broadcast/12208/consumer.shtmlDATASOURCE:
AstraZeneca CONTACT: MultiVu Media Relations, 1-800-653-5313, ext.
3, for AstraZeneca Web site: http://www.multivu.com/
Copyright